MAPT and Alzheimer disease: Strategies aimed at protecting oligodendrocytes from Aβ toxicity, enhancing OPC differentiation and myelin repair, and addressing tau pathology within oligodendrocytes may offer novel approaches to slowing disease progression and improving cognitive function in AD [106,113].